Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionCorundum Group, Inc.
Latest Disclosed Ownership25,726 shares
Latest Disclosed Value $ 1,560,282
Corundum Group, Inc. reports 8.85% increase in ownership of BRM / Bristol-Myers Squibb Company

On April 20, 2026 - Corundum Group, Inc. filed a 13F-HR form disclosing ownership of 25,726 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $1,348,557 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 12, 2026 disclosing 23,634 shares of Bristol-Myers Squibb Company. This represents a change in shares of 8.85% during the quarter. The current value of the position is $1,220,184 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-20 2026-03-31 13F BRISTOL MYERS SQUIBB CS 110122108 25,726 2,092 8.85 1,560 22.45 0.5215
2026-01-12 2025-12-31 13F BRISTOL MYERS SQUIBB CS 110122108 23,634 -1,811 -7.12 1,275 11.07 0.4278
2025-10-24 2025-09-30 13F BRISTOL MYERS SQUIBB CS 110122108 25,445 -33 -0.13 1,148 -2.71 0.4715
2025-07-21 2025-06-30 13F BRISTOL MYERS SQUIBB CS 110122108 25,478 140 0.55 1,179 -23.69 0.5215
2025-04-23 2025-03-31 13F BRISTOL MYERS SQUIBB CS 110122108 25,338 -18,196 -41.80 1,545 -37.25 0.7411
2025-01-16 2024-12-31 13F BRISTOL MYERS SQUIBB CS 110122108 43,534 17,596 67.84 2,462 83.46 0.9194
2024-10-21 2024-09-30 13F BRISTOL-MYERS SQUIBB CS 110122108 25,938 -2,257 -8.00 1,342 14.70 0.6123
2024-07-17 2024-06-30 13F BRISTOL-MYERS SQUIBB CS 110122108 28,195 17,693 168.47 1,171 105.62 0.4575
2024-04-15 2024-03-31 13F BRISTOL-MYERS SQUIBB CS 110122108 10,502 6,084 137.71 570 151.77 0.2747
2024-01-24 2023-12-31 13F BRISTOL-MYERS SQUIBB CS 110122108 4,418 -3,470 -43.99 227 -50.55 0.1137
2023-10-17 2023-09-30 13F BRISTOL-MYERS SQUIBB CS 110122108 7,888 -953 -10.78 458 -19.12 0.2601
2023-07-21 2023-06-30 13F BRISTOL-MYERS SQUIBB CS 110122108 8,841 -6,526 -42.47 565 -46.95 0.2820
2023-04-24 2023-03-31 13F BRISTOL-MYERS SQUIBB CS 110122108 15,367 7,617 98.28 1,065 0.5038
2023-01-12 2022-12-31 13F BRISTOL-MYERS SQUIBB CS 110122108 7,750 387 5.26 1 -100.00 0.3151
2022-10-18 2022-09-30 13F BRISTOL-MYERS SQUIBB CS 110122108 7,363 423 6.10 523 -2.06 0.3290
2022-07-25 2022-06-30 13F BRISTOL-MYERS SQUIBB CS 110122108 6,940 -1,413 -16.92 534 -12.46 0.3608
2022-05-02 2022-03-31 13F BRISTOL-MYERS SQUIBB CS 110122108 8,353 249 3.07 610 20.79 0.5669
2022-02-07 2021-12-31 13F BRISTOL-MYERS SQUIBB CS 110122108 8,104 866 11.96 505 17.99 0.3288
2021-11-02 2021-09-30 13F BRISTOL-MYERS SQUIBB CS 110122108 7,238 861 13.50 428 0.47 0.3173
2021-08-02 2021-06-30 13F BRISTOL-MYERS SQUIBB CS 110122108 6,377 981 18.18 426 24.93 0.2794
2021-05-10 2021-03-31 13F BRISTOL-MYERS SQUIBB CS 110122108 5,396 319 6.28 341 8.25 0.2665
2021-02-03 2020-12-31 13F BRISTOL-MYERS SQUIBB CS 110122108 5,077 190 3.89 315 6.78 0.2625
2020-11-12 2020-09-30 13F/A-1 BRISTOL-MYERS SQUIBB CS 110122108 4,887 459 10.37 295 13.46 0.2858
2020-08-07 2020-06-30 13F/A-1 BRISTOL MYERS SQUIBB CS 110122108 4,428 -373 -7.77 260 -2.99 0.3118
2020-05-07 2020-03-31 13F/A-1 BRISTOL MYERS SQUIBB CS 110122108 4,801 -540 -10.11 268 -21.87 0.3811
2020-01-28 2019-12-31 13F BRISTOL MYERS SQUIBB CS 110122108 5,341 184 3.57 343 30.92 0.3602
2019-11-01 2019-09-30 13F/A-1 BRISTOL MYERS SQUIBB CS 110122108 5,157 -3 -0.06 262 11.97 0.3035
2019-08-02 2019-06-30 13F BRISTOL MYERS SQUIBB CS 110122108 5,160 38 0.74 234 -4.10 0.2688
2019-05-08 2019-03-31 13F BRISTOL MYERS SQUIBB CS 110122108 5,122 5,122 244 0.2792
2019-02-19 2018-12-31 13F BRISTOL MYERS SQUIBB CS 110122108 0 -4,069 -100.00 0 -100.00
2018-08-07 2018-06-30 13F BRISTOL MYERS SQUIBB CS 110122108 4,069 189 4.87 225 -8.16 0.2774
2018-05-08 2018-03-31 13F BRISTOL MYERS SQUIBB CS 110122108 3,880 -798 -17.06 245 -14.63 0.2649
2018-02-13 2017-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 4,678 4 0.09 287 -3.69 0.3097
2017-11-03 2017-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 4,674 4,674 298 0.3141
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.